Unicycive Therapeutics In...
(UNCY)
undefined
undefined%
At close: undefined
0.74
3.61%
After-hours Dec 13, 2024, 05:09 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | 675.00K | 951.00K | - | - | - | - |
Cost of Revenue | - | 7.00K | 1K | - | - | - |
Gross Profit | 675.00K | 944.00K | -1K | - | - | - |
Operating Income | -20.77M | -18.05M | -8.98M | -2.02M | -1.96M | -952.00K |
Interest Income | 615.00K | 6.00K | 628.00K | 244.00K | 139.00K | 168.00K |
Pretax Income | -30.54M | -18.06M | -10.02M | -2.26M | -2.17M | -1.12M |
Net Income | -30.54M | -18.06M | -10.63M | -2.51M | -2.30M | -1.12M |
Selling & General & Admin | 8.55M | 6.57M | 2.90M | 1.00M | 1.17M | 608.00K |
Research & Development | 12.90M | 12.44M | 6.08M | 1.01M | 795.00K | 344.00K |
Other Expenses | - | - | - | - | - | - |
Operating Expenses | 21.45M | 19.00M | 8.98M | 2.02M | 1.96M | 952.00K |
Interest Expense | 82.00K | 6.00K | 628.00K | 244.00K | 139.00K | - |
Selling & Marketing Expenses | - | - | - | - | - | - |
Cost & Expenses | 21.45M | 19.00M | 8.98M | 2.02M | 1.96M | 952.00K |
Income Tax | - | 6.00K | 615.00K | 244.00K | 139.00K | -952.00K |
Shares Outstanding (Basic) | 24.54M | 15.06M | 15.00M | 15.25M | 8.43M | 7.94M |
Shares Outstanding (Diluted) | 24.54M | 15.06M | 15.00M | 15.25M | 8.47M | 7.94M |
EPS (Basic) | -1.28 | -1.2 | -0.71 | -0.16 | -0.27 | -0.14 |
EPS (Diluted) | -1.28 | -1.2 | -0.71 | -0.16 | -0.27 | -0.14 |
EBITDA | -30.18M | -18.05M | -8.98M | - | -63.00K | - |
Depreciation & Amortization | 284.00K | 7.00K | 1K | 2.02M | 1.96M | 952.00K |